Navigation Links
Growth in the Functional Food Sector Gives a Hearty Boost to the Heart Health Ingredients Market

LONDON, Jan. 13 /PRNewswire/ -- The European heart health ingredients market is developing lucratively due to the growth in the functional foods sector, triggered by a global fitness fad among consumers. Extensive media coverage has heightened consumer awareness about the fatality of cardiovascular disease (CVD) and the ill effects of obesity, heightening interest towards low fat and heart-healthy food products.


New analysis from Frost & Sullivan (, European Heart Health Ingredients Market, finds that the market earned revenues of $545.0 million in 2008 and estimates this to reach $2.0 billion in 2014.

"A variety of ingredients positioned for heart-health, with their functional benefits, is increasingly used for the fortification of various food and beverage applications," says Frost & Sullivan Research Analyst Chandrasekhar S. "The preventive cost of CVD by virtue of these ingredients is much cheaper for the consumers than the cost of its treatment."

However, the heart health ingredients market is greatly restrained by the European Union (EU) food-labelling directive of 2000, which prevents health claims being made on products. For instance, in the United States, the health claim given to barley beta-glucans by the Food and Drug Administration (FDA) helps it differentiate from other fibres in the competitive market scenario. A similar European regulation would benefit the European heart health market.

Nonetheless, European manufacturers have submitted their dossiers to the European Food Safety Authority (EFSA) for the usage of health claims for their ingredients, focussing more on scientific and research back up to establish the effects of the ingredients on the human heart.

"Manufacturers, with the help of industry associations such as the Global Organization for Eicosapentaenoic acid and Docosahexaenoic acid (GOED) are lobbying for the usage of health claims," notes Chandrasekhar. "They are also involved in extensive branding and promotional activities to increase consumer awareness on CVD and the positive impact of the various ingredients, thereby enhancing the credibility of such awareness campaigns."

Overall, heart health ingredients manufacturers can retain their competitive edge by utilizing an astute combination of research, product development and marketing strategies.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European heart health ingredients market, then send an e-mail to Katja Feick, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Heart Health Ingredients Market is part of the Food & Beverage Ingredients Growth Partnership Service program, which also includes research in the following markets: Southeast Asia nutraceuticals report, the U.S. and European dietary supplements market, the U.S. and European omega-3, and omega-6 markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit

European Heart Health Ingredients Market


    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. High pollution linked to poor lung function growth in children in Mexico City
2. Researchers develop long-lasting growth hormone
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
5. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
6. AWT Management Announce Aggressive Growth and Acquisition Strategy
7. Cynosure to Present at the Maxim Group Growth Conference
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
10. Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
11. Spectranetics to Present at The A.G Edwards Growth Conference on September 18
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... Ruth Pearson ... brutal lupus flare-up. Unable to walk without assistance and quickly losing hope of recovering ... then a miracle happened. , Pearson was attending a women’s retreat when she experienced ...
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition ... funds for Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday ... from patients including their ability to work and be productive, to do simple daily ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Royal River Natural ... new study that found post-menopausal women who took the nutritional supplement creatine, along with ... who trained but did not take creatine. , The report is part of the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... leadless pacemakers in the U.S. and is the only hospital in the region ... largest clinical data presentation of transcatheter pacing patients were revealed recently at a ...
(Date:12/1/2015)... ... 01, 2015 , ... December 1, 2015 -- InstantLabs is ... growing product line of food safety and seafood fraud prevention tools. , The ... allow InstantLabs to offer fast, reliable species identification for the four most popular ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Russia has always been a ... new drugs registered in Europe in 2015 were ... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... Russia has always been a country of choice for global ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... 1, 2015  The migration to value-based care ... care plans that help patients stay healthy and ... be digitally enabled, incorporate care guidelines and be ... They will also allow all stakeholders to collaborate ... is optimal. That is the vision, however, research ...
Breaking Medicine Technology: